The plasmatic levels of 1,3-beta-d-glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863371 | PMC |
| http://dx.doi.org/10.1128/CVI.00038-10 | DOI Listing |
Publication Analysis
Top Keywords
invasive fungal
8
bdg test
8
high levels
4
levels beta-d-glucan
4
beta-d-glucan immunocompromised
4
immunocompromised children
4
children proven
4
proven invasive
4
fungal disease
4
disease plasmatic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!